WebMar 5, 2024 · For the twelve months ended December 31st, 2024 vs December 31st, 2016, Ironwood Pharmaceuticals reported revenue of $298.28MM vs $273.96MM (up 8.88%) and basic earnings per share -$0.78 vs -$0.56. WebApr 6, 2024 · 219. Free-Float. 97,9%. More Financials. Company. Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company, which is advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its ...
Ironwood Pharmaceuticals, Inc. - Allergan Acquires Rights To Ironwood…
WebFeb 17, 2024 · Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel … Web1 day ago · Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the ... greek cabbage recipes
Ironwood Pharmaceuticals Jobs and Company Culture
WebIronwood Pharmaceuticals 6 years 8 months Executive Clinical Sales Consultant Ironwood Pharmaceuticals Mar 2024 - Present 2 months. Detroit, Michigan, United States Senior … WebIronwood Pharmaceuticals Salaries How much do Ironwood Pharmaceuticals employees make? Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. Research & Science Based on 35 salaries Senior Associate Scientist 5 salaries Scientist 4 salaries View More Business Based on 20 salaries Director 7 salaries WebFeb 17, 2024 · Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, … flovent information